BNP Paribas Financial Markets
AUXL

BNP Paribas Financial Markets’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

BNP Paribas Financial Markets’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,970
Closed -$88.7K – 4054
2014
Q3 		$88.7K Sell
2,970
-5,502
-65% -$117K ﹤0.01% 2262
2014
Q2 		$170K Buy
+8,472
New +$194K ﹤0.01% 1856
2014
Q1 		– Sell
-45,541
Closed -$945K – 4163
2013
Q4 		$945K Buy
45,541
+32,069
+238% +$605K ﹤0.01% 1077
2013
Q3 		$245K Sell
13,472
-16,930
-56% -$306K ﹤0.01% 2083
2013
Q2 		$506K Buy
+30,402
New +$486K ﹤0.01% 1544

Other funds holding AUXL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets's AUXL Position: Q4 2014 in Review

BNP Paribas Financial Markets sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2014, closing a stake of 2,970 shares — an estimated $88.7K sold.

BNP Paribas Financial Markets first reported a position in AUXL in Q2 2013 and held it in 5 quarters. The position peaked at $945K in Q4 2013. 158 funds tracked by Wall St. Rank hold AUXL as of Q4 2014.

  • BNP Paribas Financial Markets reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 2,970 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2014, an estimated $88.7K.
  • BNP Paribas Financial Markets first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • BNP Paribas Financial Markets's AUXILIUM PHARAMCEUTICALS INC position peaked at $945K in Q4 2013.
  • 158 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2014, filed 11 Feb 2015.